SCHEMBL3231998

SCHEMBL3231998

Cc1[nH]c2c(F)c(Br)cc(C)c2c1CCN

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KRAS P01116 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.38
HTR1D P28221 3/20 0.35
HTR6 P50406 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
HTR7 P34969 1/20 0.35
HTR3A P46098 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TAAR1 Q96RJ0 2/20 0.33
RAD52 P43351 1/20 0.30
BLM P54132 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
HRH1 P35367 1/20 0.30
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3234397 0.84 KRAS (0.42) KRASSMN1; SMN2HTR1DHTR6CYP1A2
SCHEMBL13496829 0.82 KRAS (0.41) KRASSMN1; SMN2HTR1DHTR6CYP1A2
SCHEMBL3235011 0.80 TAAR1 (0.42) KRASSMN1; SMN2HTR1DHTR6CYP1A2
SCHEMBL3234804 0.77 CYP1A2 (0.43) KRASSMN1; SMN2HTR1DHTR6CYP1A2
SCHEMBL3638115 0.76 KRAS (0.43) KRASSMN1; SMN2HTR1DHTR6CYP1A2
Hydrochloric Acid SCHEMBL3622627 0.76 SMN1; SMN2 (0.43) KRASSMN1; SMN2HTR1DHTR6CYP1A2
SCHEMBL3235519 0.75 KRAS (0.45) KRASSMN1; SMN2HTR1DHTR6CYP1A2
Hydrochloric Acid SCHEMBL3582811 0.74 SMN1; SMN2 (0.47) KRASSMN1; SMN2HTR1DHTR6CYP1A2
SCHEMBL3232722 0.72 KRAS (0.45) KRASSMN1; SMN2HTR1DHTR6CYP1A2
SCHEMBL13496942 0.72 KRAS (0.42) KRASSMN1; SMN2HTR1DHTR6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO disclosed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed